A pandemia de Covid-19 aumenta os riscos de medicamentos, os jovens subestimam os perigos da cannabis

No passado 24 Anos, a potência psicoativa da cannabis quadruplicou em partes do mundo. Embora haja evidências de que o uso de cannabis está associado a várias lesões de saúde e outras, especialmente entre os usuários de longo prazo, a proporção de adolescentes que consideram a cannabis nociva diminuiu em 40%. A maioria dos países relatou um aumento no uso de cannabis durante a pandemia de Covid-19. In a survey of health professionals in 77 countries, 42% asserted an increase in cannabis use. During the same period, the non-medical use of medical drugs containing cannabis also increased.

Rebound and change of drug market

The report shows that after the initial chaos at the beginning of the new crown pandemic, the drug market has quickly resumed operations; this emergency triggered or accelerated some of the original trafficking movements in the global drug market. These include: the increasing transportation of illicit drugs, the increasing frequency of land and water routes used for trafficking, the increased use of private jets for drug trafficking, and the surge in the use of non-contact methods to deliver drugs to end consumers.

The report also pointed out that the European cocaine supply chain is becoming diversified, pushing prices down and improving quality, so that the European cocaine market may expand further, which may expand the potential harm caused by this drug in the region.

The potential impact of the COVID-19 pandemic

According to the report, the COVID-19 pandemic has given birth to a more flexible service delivery model, which has led to innovation and adjustment of drug prevention and treatment services. Due to the COVID-19 pandemic, many countries have introduced or expanded telemedicine services, which means that for drug users, medical staff can now provide consultation or preliminary assessments over the phone and use electronic systems to prescribe controlled substances